Catalyst Biosciences Inc buy stratec
Start price
08.12.17
/
50%
€3.48
Target price
19.01.18
€8.57
Performance (%)
146.76%
End price
19.01.18
€8.59
Summary
This prediction ended on 19.01.18 with a price of €8.59. The BUY prediction by stratec for Catalyst Biosciences Inc saw massive gains of 146.76%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
Comments by stratec for this prediction
In the thread Catalyst Biosciences Inc diskutieren
stratec stimmt der Buy-Einschätzung von melinda zu
stratec stimmt am 08.12.2017 der Buy-Einschätzung von melinda mit dem Kursziel 5,8$ zu.
Überschrift: pharma
- Catalyst Biosciences (NASDAQ:CBIO) initiated with Buy rating and $19 (166% upside) price target by B. Riley FBR.
(Vom Mitglied beendet)